Carregant...
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma
MYC is a major oncogenic driver of Multiple Myeloma (MM) and yet almost no therapeutic agents exist that target MYC in MM. Here we report that the let-7 biogenesis inhibitor LIN28B correlates with MYC expression in MM and is associated with adverse outcome. We also demonstrate that the LIN28B/let-7...
Guardat en:
| Publicat a: | Leukemia |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5382134/ https://ncbi.nlm.nih.gov/pubmed/27773931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2016.296 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|